Microbix Biosystems Inc (TSX:MBX)
C$ 0.345 -0.015 (-4.17%) Market Cap: 47.16 Mil Enterprise Value: 40.71 Mil PE Ratio: 9.09 PB Ratio: 1.69 GF Score: 66/100

Microbix Biosystems Inc at Tarsier Capital Management MicroCap Leadership Summit (Virtual) Transcript

Sep 24, 2021 / NTS GMT
Release Date Price: C$0.66 (+8.20%)
Ian Cassel
MicroCapClub LLC - Founder

Okay. Our first presenter today is Microbix. And the Microbix Biosystems was founded more than 30 years ago to provide viral antigens to the global diagnostics industry. In 2017, after many years of kind of low growth and the Board appointed Cameron Groome, the CEO of the company, and Groome leveraged Microbix expertise in its highly regulated industry to develop 2 new higher-margin product lines.

In just a few years, Microbix has transformed from a low-growth, money-losing company to a fast-growing, highly profitable and more diversified corporation. We're honored to have Cameron Groome, CEO of Microbix, with us today.

And as a reminder, once again, if you have questions during this presentation, click the Q&A button at the bottom of the screen, and we'll get to them after his presentation. Cameron, thanks for being here. The floor is yours.

Cameron L. Groome
Microbix Biosystems Inc. - President, CEO & Director

Well, thank you very much, Ian. That's a great intro and really sets up for what we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot